FIFTH THIRD BANCORP - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 109 filers reported holding NEWLINK GENETICS CORP in Q2 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.0%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q4 2019$3,000
+50.0%
1,0000.0%0.00%
Q3 2019$2,000
+100.0%
1,0000.0%0.00%
Q2 2019$1,000
-50.0%
1,0000.0%0.00%
Q1 2019$2,0000.0%1,0000.0%0.00%
Q4 2018$2,0000.0%1,0000.0%0.00%
Q3 2018$2,000
-60.0%
1,0000.0%0.00%
Q2 2018$5,000
-28.6%
1,0000.0%0.00%
Q1 2018$7,000
-12.5%
1,0000.0%0.00%
Q4 2017$8,000
-20.0%
1,0000.0%0.00%
Q3 2017$10,000
+42.9%
1,0000.0%0.00%
Q2 2017$7,000
-70.8%
1,0000.0%0.00%
Q1 2017$24,000
+140.0%
1,0000.0%0.00%
Q4 2016$10,000
-33.3%
1,0000.0%0.00%
Q3 2016$15,000
+36.4%
1,0000.0%0.00%
Q2 2016$11,000
-38.9%
1,0000.0%0.00%
Q1 2016$18,000
-50.0%
1,0000.0%0.00%
Q4 2015$36,0000.0%1,0000.0%0.00%
Q3 2015$36,0001,0000.00%
Other shareholders
NEWLINK GENETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 93,533$962,0001.69%
WALL STREET ASSOCIATES 108,900$1,119,0000.74%
NORTHWEST WEALTH MANAGEMENT, LLC 57,482$591,0000.60%
Orbimed Advisors 1,991,700$20,475,0000.26%
TFS CAPITAL LLC 92,041$946,0000.25%
Intrinsic Edge Capital Management LLC 40,000$411,0000.18%
SECOR Capital Advisors, LP 100,529$1,033,0000.13%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 176,077$1,810,0000.12%
Piermont Capital Management Inc. 41,400$426,0000.10%
Vident Investment Advisory, LLC 67,209$691,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders